You are here

Vaxneuvance

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

Merck outflanks Pfizer's 20-valent shot with pneumococcal vaccine approval for kids

Endpoints

Wed, 06/22/22 - 10:57 am

pneumococcal disease

Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use

Fierce Pharma

Fri, 04/1/22 - 10:45 am

pneumococcal disease

Pfizer, Merck next-gen pneumococcal vaccines score key CDC panel's backing on way to rival rollouts

Fierce Pharma

Thu, 10/21/21 - 11:20 pm

pneumococcal disease

Merck's 15-strain flu shot matches Prevnar 13 in late-stage infant study, but Pfizer's next-gen shot looms

Endpoints

Wed, 08/25/21 - 11:16 am

clinical trials

Merck's Vaxneuvance lead departs to help develop rival vaccine at Affinivax

Fierce Biotech

Mon, 08/9/21 - 12:12 pm

Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?

Motley Fool

Sun, 08/1/21 - 11:50 pm

pneumococcal disease

Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival

Benzinga

Mon, 07/19/21 - 10:55 am

pneumococcal disease